The Discounted Cash Flow (DCF) valuation of Sutro Biopharma Inc (STRO) is (78.82) USD. With the latest stock price at 0.88 USD, the upside of Sutro Biopharma Inc based on DCF is -9073.6%.
Based on the latest price of 0.88 USD and our DCF valuation, Sutro Biopharma Inc (STRO) is a sell. selling STRO stocks now will result in a potential gain of 9073.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.3% - 9.5% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (147.39) - (54.68) | (78.82) |
| Upside | -16881.6% - -6325.6% | -9073.6% |